The Moving Average Convergence Divergence (MACD) for AFLG turned positive on October 05, 2026. Looking at past instances where AFLG's MACD turned positive, the stock continued to rise in 46 of 51 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on AFLG as a result. In 63 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The 10-day moving average for AFLG crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +0.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFLG advanced for three days, in 288 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
AFLG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 304 of 384 cases where AFLG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 66 cases where AFLG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
AFLG moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFLG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IVZ declined for three days, in 196 of 282 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In 52 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
IVZ moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IVZ crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for IVZ entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IVZ's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in 229 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.349) is normal, around the industry mean (3.246). P/E Ratio (19.476) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (1.319). Dividend Yield (0.028) settles around the average of (0.081) among similar stocks. P/S Ratio (1.981) is also within normal values, averaging (15.798).
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
IVZ | ||
|---|---|---|
OUTLOOK RATING 1..100 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 52 | |
SMR RATING 1..100 | 92 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 24 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AFLG | IVZ | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 88% |
| Stochastic ODDS (%) | 3 days ago 70% | 3 days ago 80% |
| Momentum ODDS (%) | 3 days ago 81% | 3 days ago 63% |
| MACD ODDS (%) | 3 days ago 90% | N/A |
| TrendWeek ODDS (%) | 3 days ago 70% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 81% | 3 days ago 69% |
| Advances ODDS (%) | 10 days ago 82% | 17 days ago 69% |
| Declines ODDS (%) | 19 days ago 69% | 5 days ago 70% |
| BollingerBands ODDS (%) | 7 days ago 83% | 3 days ago 77% |
| Aroon ODDS (%) | 3 days ago 79% | 3 days ago 62% |
A.I.dvisor indicates that over the last year, AFLG has been loosely correlated with IVZ. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AFLG jumps, then IVZ could also see price increases.
| Ticker / NAME | Correlation To AFLG | 1D Price Change % | ||
|---|---|---|---|---|
| AFLG | 100% | -0.91% | ||
| IVZ - AFLG | 62% Loosely correlated | -2.08% | ||
| TEL - AFLG | 61% Loosely correlated | -0.16% | ||
| DAL - AFLG | 59% Loosely correlated | -3.47% | ||
| CAT - AFLG | 58% Loosely correlated | -0.66% | ||
| ROK - AFLG | 58% Loosely correlated | +1.00% | ||
More | ||||
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BLK. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BLK could also see price increases.